Drug factory · FDA FEI 3002807400

Siegfried PharmaChemikalien Minden Gmbh

Karlstrasse 15-39, 42-44, Minden, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Apr 21, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2012: 1 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
TheophyllineMakes the active ingredient ENDO USA, Inc. 52244-100, 52244-200, 52244-300 +1

FDA inspection history

EndedResultProgramProblems noted
Apr 21, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 8, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 3, 2017No problems foundDrug Quality Assurance—
Oct 24, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 10, 2012Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.